Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 123-138, 2023.
Article
in En
| MEDLINE
| ID: mdl-36741246
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Screening_studies
Language:
En
Journal:
J Hepatocell Carcinoma
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: